drugset / Trial / NCT00119665
Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes
RandomizedParallel-groupDouble-blindTreatment
Summary
The researchers propose a Phase II randomized, double-blind, placebo-controlled trial of 180 healthy postmenopausal women experiencing at least 5 hot flashes per day or 35 hot flashes per week. Women will be randomized to one of three arms: 4.5 grams/day (dry weight of extract) of MF101, 9.0 grams/day (dry weight of extract) of MF101 or placebo for 12 weeks.
Timeline
- Start
- 2006-02
- Primary completion
- —
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MF101 | Traditional medicine (herbal / TCM) | 4.5 g | — |
| Subject | MF101 | Traditional medicine (herbal / TCM) | 9 g | — |
Indications
No indication recorded.